These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 673085)

  • 1. [Treatment of multiple sclerosis with levamisole and azathioprine. Comparison of the effectiveness, of an 'immunostimulative' and 'immunosuppressive' treatment (author's transl)].
    Patzold U; Haller P; Haas J; Pocklington P; Deicher H
    Nervenarzt; 1978 May; 49(5):285-94. PubMed ID: 673085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunosuppressive treatment of multiple sclerosis. 4. Results of treatment with azathioprine and antilymphocyte globulin (author's transl)].
    Frick E; Angstwurm H; Blomer R; Strauss G
    MMW Munch Med Wochenschr; 1977 Sep; 119(35):1111-4. PubMed ID: 408666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of multiple sclerosis by Azathioprine. About 77 cases studied during 10 years (author's transl)].
    Aimard G; Confavreux C; Trouillas P; Devic M
    Rev Neurol (Paris); 1978 Mar; 134(3):215-22. PubMed ID: 360353
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative analysis of the use of levamisole and pyrogenal in the treatment of multiple sclerosis].
    Mukhtarova AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):366-7. PubMed ID: 3873154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive therapy of multiple sclerosis using cyclophosphamide and imuran. Report on 57 cases].
    Göpel W; Benkenstein H; Banzhaf M
    Dtsch Gesundheitsw; 1972 Oct; 27(41):1955-61. PubMed ID: 4637249
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further observations on the effect of azathioprine on chronic nonremitting multiple sclerosis.
    Rosen JA
    Trans Am Neurol Assoc; 1978; 103():209-12. PubMed ID: 757060
    [No Abstract]   [Full Text] [Related]  

  • 9. [Levamisole treatment in multiple sclerosis and spastic pyramidal syndromes].
    Truşcă E; Stoica I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(2):125-35. PubMed ID: 6216567
    [No Abstract]   [Full Text] [Related]  

  • 10. Azathioprine in multiple sclerosis: the cons.
    Silberberg DH
    Neurology; 1988 Jul; 38(7 Suppl 2):24-7. PubMed ID: 3290710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term immunosuppression in multiple sclerosis: evaluation of treatments begun before 1972].
    Sabouraud O; Oger J; Darcel F; Madigand M; Merienne M
    Rev Neurol (Paris); 1984; 140(2):125-30. PubMed ID: 6710012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
    Schluep M; Steck AJ; Despland PA; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Rundsch Med Prax; 1991 Jun; 80(24):670-2. PubMed ID: 2068440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
    Lance EM; Kremer M; Abbosh J; Jones VE; Knight S; Medawar PB
    Clin Exp Immunol; 1975 Jul; 21(1):1-12. PubMed ID: 1237376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of multiple sclerosis with azathioprine (Imuran)].
    Ciesielski T; Burczyk-Popko I; Goralski H; Sypniewski J; Cendrowski W
    Pol Tyg Lek; 1974 Jan; 29(3):101-2. PubMed ID: 4594954
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunomodulating treatment of immunologic disorders in chronic pulmonary heart disease].
    Skakal'skaia LM
    Vrach Delo; 1980 May; (5):36-40. PubMed ID: 6967235
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymectomy in multiple sclerosis. Two preliminary trials.
    Ferguson TB; Clifford DB; Montgomery EB; Bruns KA; McGregor PJ; Trotter JL
    J Thorac Cardiovasc Surg; 1983 Jan; 85(1):88-93. PubMed ID: 6848891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
    Kappos L; Patzold U; Dommasch D; Poser S; Haas J; Krauseneck P; Malin JP; Fierz W; Graffenried BU; Gugerli US
    Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Haematological changes following long-term treatment of multiple sclerosis and myasthenia with azathioprin (author's transl)].
    Haas J; Patzold U
    Nervenarzt; 1982 Feb; 53(2):105-9. PubMed ID: 6801533
    [No Abstract]   [Full Text] [Related]  

  • 19. [The action of levamisole in multiple sclerosis and in spastic pyramidal syndromes].
    Truşcă E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1980; 25(3):211-8. PubMed ID: 6451012
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multiple sclerosis--current status of therapy].
    Reichel D; Kölmel HW
    Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.